User profiles for Géraldine Gazzo
 | Géraldine GazzoPhD in Neuroscience Verified email at unistra.fr Cited by 160 |
Cholecalciferol (Vitamin D3) Reduces Rat Neuropathic Pain by Modulating Opioid Signaling
P Poisbeau, M Aouad, G Gazzo, A Lacaud… - Molecular …, 2019 - Springer
The impact of vitamin D on sensory function, including pain processing, has been receiving
increasing attention. Indeed, vitamin D deficiency is associated with various chronic pain …
increasing attention. Indeed, vitamin D deficiency is associated with various chronic pain …
Identification of bacterial lipopeptides as key players in IBS
…, S Maurel, G Payros, A Hueber, B Agaiz, G Gazzo… - Gut, 2023 - gut.bmj.com
Objectives Clinical studies revealed that early-life adverse events contribute to the development
of IBS in adulthood. The aim of our study was to investigate the relationship between …
of IBS in adulthood. The aim of our study was to investigate the relationship between …
Pharmacological rescue of nociceptive hypersensitivity and oxytocin analgesia impairment in a rat model of neonatal maternal separation
M Melchior, PE Juif, G Gazzo, N Petit-Demoulière… - Pain, 2018 - journals.lww.com
Oxytocin (OT), known for its neurohormonal effects around birth, has recently been suggested
for being a critical determinant in neurodevelopmental disorders. This hypothalamic …
for being a critical determinant in neurodevelopmental disorders. This hypothalamic …
Anxiolytics targeting GABAA receptors: Insights on etifoxine
Objectives: Anxiety and adjustment disorders are among the most prevalent mental health
conditions. This review focuses on γ-aminobutyric acid receptor type A (GABA A R)-mediated …
conditions. This review focuses on γ-aminobutyric acid receptor type A (GABA A R)-mediated …
[HTML][HTML] The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic …
G Gazzo, M Salgado Ferrer, P Poisbeau - Plos one, 2021 - journals.plos.org
More than 450 million people worldwide suffer from diabetes, or 1 in 11 people. Chronic
hyperglycemia degrades patients’ quality of life and the development of neuropathic pain …
hyperglycemia degrades patients’ quality of life and the development of neuropathic pain …
Overexpression of chloride importer NKCC1 contributes to the sensory-affective and sociability phenotype of rats following neonatal maternal separation
G Gazzo, M Melchior, A Caussaint, C Gieré… - Brain, Behavior, and …, 2021 - Elsevier
Background Early life stress is known to affect the development of the nervous system and
its function at a later age. It increases the risk to develop psychiatric disorders as well as …
its function at a later age. It increases the risk to develop psychiatric disorders as well as …
Analgesic and anti-edemic properties of etifoxine in models of inflammatory sensitization
G Gazzo, P Girard, N Kamoun, M Verleye… - European Journal of …, 2019 - Elsevier
Inflammatory processes are critical promoting factors of chronic pain states, mostly by
inducing peripheral and central sensitization of the nociceptive system. These processes are …
inducing peripheral and central sensitization of the nociceptive system. These processes are …
Long-lasting analgesic and neuroprotective action of the non-benzodiazepine anxiolytic etifoxine in a mouse model of neuropathic pain
Neuropathic pain is frequently associated with anxiety and major depressive disorders, which
considerably impact the overall patient experience. Favoring GABAergic inhibition through …
considerably impact the overall patient experience. Favoring GABAergic inhibition through …
Neonatal pain, still searching for the optimal approach
Background: although neonatal pain management has seen huge improvements in the past
years, many gaps between knowledge and practice still exist. Objective: to give the reader …
years, many gaps between knowledge and practice still exist. Objective: to give the reader …
The non-benzodiazepine anxiolytic etifoxine limits the sensory-affective expression of pain following streptozotocin-induced diabetic neuropathy
G Gazzo, MS Ferrer, P Poisbeau - bioRxiv, 2021 - biorxiv.org
More than 450 million people worldwide suffer from diabetes, or 1 in 11 people. Chronic
hyperglycemia degrades patients’ quality of life and the development of neuropathic pain …
hyperglycemia degrades patients’ quality of life and the development of neuropathic pain …